HYPHA LABS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0307 USD | 0.00% |
|
-7.81% | -23.25% |
| 04-29 | Hypha Labs, Inc. Appoints Craig Ellins as Chief Science Officer | CI |
| 04-15 | Digipath, Inc. has Changed its Name to Hypha Labs, Inc | CI |
Valuation
| Fiscal Period: September | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 6.276 | 5.21 | 1.037 | 2.992 | 0.526 | 1.289 |
| Enterprise Value (EV) 1 | 6.075 | 5.494 | 3.262 | 5.021 | 3.265 | 3.308 |
| P/E ratio | -3.57 x | -2.77 x | -0.42 x | -4.03 x | -0.23 x | 5.03 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 2.21 x | 2.04 x | 0.4 x | 1.19 x | 0.19 x | - |
| EV / Revenue | 2.14 x | 2.15 x | 1.27 x | 2.01 x | 1.21 x | - |
| EV / EBITDA | -4.1 x | -3.69 x | -2.56 x | -10.5 x | -2.05 x | -56.8 x |
| EV / FCF | 33.1 x | -11.1 x | -11.9 x | -24.2 x | -38.6 x | -7.44 x |
| FCF Yield | 3.02% | -9% | -8.43% | -4.13% | -2.59% | -13.4% |
| Price to Book | 6.3 x | 12.3 x | -0.96 x | -2.84 x | -0.19 x | -0.58 x |
| Nbr of stocks (in thousands) | 41,564 | 48,156 | 57,613 | 71,230 | 75,147 | 87,097 |
| Reference price 2 | 0.1510 | 0.1082 | 0.0180 | 0.0420 | 0.007000 | 0.0148 |
| Announcement Date | 12/27/18 | 12/31/19 | 1/29/21 | 12/29/21 | 1/17/23 | 1/16/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: September | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 2.84 | 2.553 | 2.574 | 2.504 | 2.7 | - |
| EBITDA 1 | -1.481 | -1.487 | -1.276 | -0.4803 | -1.593 | -0.0582 |
| EBIT 1 | -1.759 | -1.748 | -1.6 | -0.7724 | -1.797 | -0.2624 |
| Operating Margin | -61.93% | -68.48% | -62.14% | -30.85% | -66.55% | - |
| Earnings before Tax (EBT) 1 | -1.654 | -1.805 | -2.309 | -0.6865 | -2.057 | -0.6817 |
| Net income 1 | -1.654 | -1.805 | -2.309 | -0.6865 | -2.057 | 0.2468 |
| Net margin | -58.23% | -70.73% | -89.71% | -27.42% | -76.19% | - |
| EPS 2 | -0.0423 | -0.0391 | -0.0432 | -0.0104 | -0.0303 | 0.002940 |
| Free Cash Flow 1 | 0.1837 | -0.4945 | -0.2751 | -0.2074 | -0.0846 | -0.4445 |
| FCF margin | 6.47% | -19.37% | -10.69% | -8.29% | -3.13% | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 12/27/18 | 12/31/19 | 1/29/21 | 12/29/21 | 1/17/23 | 1/16/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: September | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 0.28 | 2.22 | 2.03 | 2.74 | 2.02 |
| Net Cash position 1 | 0.2 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | -0.1903 x | -1.743 x | -4.226 x | -1.72 x | -34.67 x |
| Free Cash Flow 1 | 0.18 | -0.49 | -0.28 | -0.21 | -0.08 | -0.44 |
| ROE (net income / shareholders' equity) | -137% | -251% | 696% | 64.1% | 119% | 31.8% |
| ROA (Net income/ Total Assets) | -74% | -79.3% | -63.6% | -26.3% | -69.6% | -11.9% |
| Assets 1 | 2.234 | 2.276 | 3.631 | 2.614 | 2.956 | -2.069 |
| Book Value Per Share 2 | 0.0200 | 0.0100 | -0.0200 | -0.0100 | -0.0400 | -0.0300 |
| Cash Flow per Share 2 | 0 | 0.0100 | 0 | 0 | 0 | 0 |
| Capex 1 | 0.21 | 0.05 | 0.14 | 0.06 | 0.02 | - |
| Capex / Sales | 7.3% | 1.77% | 5.48% | 2.24% | 0.66% | - |
| Announcement Date | 12/27/18 | 12/31/19 | 1/29/21 | 12/29/21 | 1/17/23 | 1/16/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -23.25% | 3.23M | |
| +15.06% | 3.37B | |
| -95.58% | 1.61B | |
| -2.18% | 1.57B | |
| -0.81% | 1.28B | |
| -7.60% | 1.24B | |
| -11.30% | 1.23B | |
| -.--% | 1.22B | |
| 0.00% | 1.2B | |
| -8.91% | 1.17B |
- Stock Market
- Equities
- DIGP Stock
- Financials Hypha Labs, Inc.
